Abstract
Determining protein thermal stability is integral in biomedical research. Here, with the use of two thermal stability assays, we show the melting temperature of amyloid precursor protein, an Alzheimer’s disease related protein. The average melting temperature for amyloid precursor protein of 55.9 °C was derived from differential scanning fluorometry (55.1 ± 0.3 °C) and cellular thermal melt (56.7 ± 0.7 °C). These experimental methods have significant application for Alzheimer’s disease research including their use for amyloid precursor protein stability profiling and for the identification of additional binding partners to further elucidate novel protein functions.
Abbreviations
- TSA:
-
Thermal shift assay
- CETSA:
-
Cellular thermal shift assay
- DSF:
-
Differential scanning fluorometry
- AD:
-
Alzheimer’s disease
- APP:
-
Amyloid precursor protein
- IMAC:
-
Immobilized metal-ion affinity chromatography
References
Zhang R, Monsma F (2010) Fluorescence-based thermal shift assays. Curr Opin Drug Discov Devel 13(4):389–402
Niesen FH, Berglund H, Vedadi M (2007) The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2:2212. https://doi.org/10.1038/nprot.2007.321
Senisterra GA, Ghanei H, Khutoreskaya G, Dobrovetsky E, Edwards AM, Privé GG, Vedadi M (2010) Assessing the stability of membrane proteins to detect ligand binding using differential static light scattering. J Biomol Screen 15(3):314–320. https://doi.org/10.1177/1087057109357117
Molina DM, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, Sreekumar L, Cao Y, Nordlund P (2013) Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341(6141):84–87. https://doi.org/10.1126/science.1233606
Molina DM, Nordlund P (2016) The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies. Annu Rev Pharmacol Toxicol 56(1):141–161. https://doi.org/10.1146/annurev-pharmtox-010715-103715
Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundbäck T, Nordlund P, Molina DM (2014) The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc 9:2100. https://doi.org/10.1038/nprot.2014.138
Martinez NJ, Asawa RR, Cyr MG, Zakharov A, Urban DJ, Roth JS, Wallgren E, Klumpp-Thomas C, Coussens NP, Rai G, Yang S-M, Hall MD, Marugan JJ, Simeonov A, Henderson MJ (2018) A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase. Sci Rep 8(1):9472. https://doi.org/10.1038/s41598-018-27834-y
Senisterra G, Chau I, Vedadi M (2012) Thermal denaturation assays in chemical biology. Assay Drug Dev Technol 10(2):128–136. https://doi.org/10.1089/adt.2011.0390
Huynh K, Partch CL (2015) Analysis of protein stability and ligand interactions by thermal shift assay. Curr Protoc Protein Sci 79(1):28.9.1–28.9.14. https://doi.org/10.1002/0471140864.ps2809s79
Layton CJ, Hellinga HW (2011) Quantitation of protein–protein interactions by thermal stability shift analysis. Protein Sci 20(8):1439–1450. https://doi.org/10.1002/pro.674
Dahlroth SL, Gurmu D, Haas J, Erlandsen H, Nordlund P (2009) Crystal structure of the shutoff and exonuclease protein from the oncogenic Kaposi’s sarcoma-associated herpesvirus. FEBS J 276(22):6636–6645. https://doi.org/10.1111/j.1742-4658.2009.07374.x
Müller UC, Deller T, Korte M (2017) Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci 18:281. https://doi.org/10.1038/nrn.2017.29
Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med 8(6):595–608. https://doi.org/10.15252/emmm.201606210
Stepanenko AA, Dmitrenko VV (2015) HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution. Gene 569(2):182–190. https://doi.org/10.1016/j.gene.2015.05.065
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671. https://doi.org/10.1038/nmeth.2089
Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, Fritz LC, Oltersdorf T (1988) Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. PNAS 85(19):7341–7345. https://doi.org/10.1073/pnas.85.19.7341
Eggert S, Gonzalez A, Thomas C, Schilling S, Schwarz S, Tischer C, Adam V, Strecker P, Schmidt V, Willnow T (2018) Dimerization leads to changes in APP (amyloid precursor protein) trafficking mediated by LRP1 and SorLA. Cell Mol Life Sci 75(2):301–322. https://doi.org/10.1007/s00018-017-2625-7
Hol EM, van Dijk R, Gerez L, Sluijs JA, Hobo B, Tonk MT, de Haan A, Kamphorst W, Fischer DF, Benne R (2003) Frameshifted β-amyloid precursor protein (APP + 1) is a secretory protein, and the level of APP + 1 in cerebrospinal fluid is linked to Alzheimer pathology. J Biol Chem 278(41):39637–39643. https://doi.org/10.1074/jbc.M302295200
Delvaux E, Bentley K, Stubbs V, Sabbagh M, Coleman PD (2013) Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes. Neurobiol Aging 34(6):1680–1686. https://doi.org/10.1016/j.neurobiolaging.2012.12.004
Geiger T, Wehner A, Schaab C, Cox J, Mann M (2012) Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol Cell Proteomics 11(3):M111.014050. https://doi.org/10.1074/mcp.M111.014050
Mahmood N, Xie J (2015) An endogenous ‘non-specific’protein detected by a His-tag antibody is human transcription regulator YY1. Data Brief 2:52–55. https://doi.org/10.1016/j.dib.2014.12.002
Groftehauge MK, Hajizadeh NR, Swann MJ, Pohl E (2015) Protein-ligand interactions investigated by thermal shift assays (TSA) and dual polarization interferometry (DPI). Acta Crystallogr Sect D 71(1):36–44. https://doi.org/10.1107/S1399004714016617
Asial I, Cheng YX, Engman H, Dollhopf M, Wu B, Nordlund P, Cornvik T (2013) Engineering protein thermostability using a generic activity-independent biophysical screen inside the cell. Nat Commun 4:2901. https://doi.org/10.1038/ncomms3901
Vedadi M, Arrowsmith CH, Allali-Hassani A, Senisterra G, Wasney GA (2010) Biophysical characterization of recombinant proteins: a key to higher structural genomics success. J Struct Biol 172(1):107–119. https://doi.org/10.1016/j.jsb.2010.05.005
Zhou H, Lu J, Liu L, Bernard D, Yang C-Y, Fernandez-Salas E, Chinnaswamy K, Layton S, Stuckey J, Yu Q, Zhou W, Pan Z, Sun Y, Wang S (2017) A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation. Nat Commun 8(1):1150. https://doi.org/10.1038/s41467-017-01243-7
Acknowledgements
We would like to acknowledge the National Research Foundation/Deutscher Akademischer Austauschdienst (DAAD170613239977) and the University of KwaZulu-Natal for funding and permission to publish the research produced here. The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Delport, A., Hewer, R. Determining the Protein Stability of Alzheimer’s Disease Protein, Amyloid Precursor Protein. Protein J 38, 419–424 (2019). https://doi.org/10.1007/s10930-019-09829-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-019-09829-4